MR-guided microwave ablation in hepatic malignancies: clinical experiences from 50 procedures

摘要

Purpose: To investigate technical success, technique efficacy, safety and outcome of MR-guided microwave ablation (MWA) in hepatic malignancies. Material and methods: In this prospective IRB-approved study, patients scheduled for percutaneous treatment of hepatic malignancies underwent MR-guided MWA in a closed-bore 1.5?T MR system. Technical success was assessed on post-procedural MR control imaging. Technique efficacy was evaluated 4?weeks after the procedure on multi-parametric MRI. Assessment of safety followed the Society of Interventional Radiology grading system. Kaplan–Meier survival estimates were calculated to evaluate overall survival (OS), time to local tumor progression (TLTP), and time to non-target progression (TNTP). Results: Between 2015 and 2019, 47 patients (60.5?±?12.2?years; 39 male) underwent 50 procedures for 58 hepatic tumors (21 hepatocellular carcinomas; 37 metastases). Mean target tumor size was 16?±?7mm (range: 6–39?mm). Technical success and technique efficacy were 100% and 98%, respectively. Lesions were treated using 2.6 applicator positions (range: 1–6). Mean energy, ablation duration per tumor, and procedure duration were 43.2?±?23.5?kJ, 26.7?±?13.1?min and 211.2?±?68.7?min, respectively. 10 minor (20%) and 3 major (6%) complications were observed. Median post-interventional hospital admission was 1?day (range: 1–19?days). Median OS was 41.6 (IQR: 26.4–) months. Local recurrence occurred after 4 procedures (8%) with TLTP ranging between 3.1 and 41.9?months. Non-target recurrence was observed in 64% of patients after a median TNTP of 13.8 (IQR 2.3–) months. Conclusion: MR-guided MWA allows for safe and successful treatment of hepatic malignancies with a high technique efficacy however with relatively long procedure durations.